Astria Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ATXS Nasdaq 2836 www.astriatx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Astria Therapeutics, Inc.

BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition - Dec 3rd, 2025 5:00 am
KLKB1 Inhibitors Market to Reach New Heights by 2034 Owing to the Launch of Novel Therapies | DelveInsight - Nov 19th, 2025 3:31 pm
Why Analysts Say the BioCryst Story Is Changing After Astria Therapeutics Acquisition - Nov 12th, 2025 3:16 pm
Astria Therapeutics, Inc. (ATXS) Reports Q3 Loss, Misses Revenue Estimates - Nov 12th, 2025 7:10 am
Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update - Nov 12th, 2025 6:00 am
Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in the ALPHA-STAR Phase 1b/2 Trial of Navenibart - Nov 6th, 2025 6:00 am
BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update - Nov 3rd, 2025 5:00 am
Astria, Viridian Therapeutics, and More Stocks See Action From Activist Investors - Oct 31st, 2025 3:42 pm
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - Oct 31st, 2025 6:00 am
BioCryst (BCRX) Soars 6.1%: Is Further Upside Left in the Stock? - Oct 16th, 2025 5:56 am
Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX - Oct 15th, 2025 8:05 am
BioCryst to buy Astria Therapeutics for $700m in enterprise value - Oct 15th, 2025 3:16 am
How the Astria Deal Is Shaping the New Story for BioCryst Pharmaceuticals - Oct 15th, 2025 1:06 am
US Equity Markets Mixed After Fed Chair Hints at End of Quantitative Tightening Program - Oct 14th, 2025 2:09 pm
Sector Update: Health Care Stocks Higher Late Afternoon - Oct 14th, 2025 1:59 pm
Top Midday Decliners - Oct 14th, 2025 12:43 pm
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Amid Escalating US-China Trade Friction - Oct 14th, 2025 6:44 am
BioCryst to Acquire Astria in Deal Valued at $700 Million - Oct 14th, 2025 5:49 am
BioCryst goes ‘all in’ on rare swelling disease with Astria deal - Oct 14th, 2025 5:32 am
BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile - Oct 14th, 2025 5:00 am